CVS agrees to pay DOJ $440 million to settle Omnicare False Claims Act case
Jul 18, 2026 – Oct 11, 2026
-
CVS's Omnicare unit settles $440 million nursing home pharmacy fraud case
CVS Health will pay the Justice Department $130 million within two weeks of final approval and the remaining $310 million by March 15, 2028, resolving a False Claims Act case a jury had valued near $950 million, contingent on Omnicare's bankruptcy sale and an August 12, 2026 court hearing.
Read this issue → -
Omnicare's 440 million dollar fraud settlement heads to bankruptcy court
CVS Health's Omnicare unit faces an August 12 bankruptcy court hearing on its July 1 settlement resolving a decade old False Claims Act case in which a jury found more than 3.3 million false claims for prescriptions dispensed without valid orders.
Read this issue → -
Omnicare confirmation hearing set for September 17 as $440 million DOJ False Claims Act settlement nears close
Creditors in Omnicare's Chapter 11 case voted on its reorganization plan by September 11, 2026, with a bankruptcy court confirmation hearing scheduled for September 17 before Judge Stacey Jernigan in the Northern District of Texas, the last formal step before the $440 million FCA settlement with DOJ and the sale to GenieRx Holding can close.
Read this issue → -
Omnicare bankruptcy plan confirmed, closing a 440 million dollar fraud settlement
A Texas bankruptcy judge confirmed CVS-owned Omnicare's Chapter 11 plan on September 17, 2026, closing a 440 million dollar settlement that resolves a 948.8 million dollar False Claims Act judgment over 3.3 million improper prescription claims; the plan pays creditors in full and takes effect in October.
Read this issue → -
Omnicare bankruptcy plan confirmed, CVS owes $130 million within 14 days of plan taking effect
CVS's long term care pharmacy subsidiary Omnicare exited Chapter 11 under a plan confirmed September 17 that requires CVS to pay $130 million to the Justice Department within 14 days of the effective date and $310 million more by March 15, 2028, settling False Claims Act allegations tied to nursing home dispensing without valid prescriptions.
Read this issue → -
CVS agrees to pay DOJ $440 million to settle Omnicare False Claims Act case
CVS agreed to a $440 million settlement with the Justice Department to resolve a roughly $949 million False Claims Act judgment against its bankrupt Omnicare long-term-care pharmacy unit, with $130 million due within 14 days of the agreement's effective date and $310 million due by March 15, 2028.
Read this issue →